rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

MDxHealth SA -

MDXH · Nasdaq

Health CareDiagnostics & LabsNot moving yet

MDXH stood above a rising 150-day average in 15 of the last 52 weekly readings, and has been out of that trend for the last 35 weeks. It is 78.8% below that average now. Diagnostics & Labs: 52% of its 44 stocks in an uptrend (+5 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 35
Industry in uptrend
52% +5 in 4 wk
Insider buys, 12 months
$2.0M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
22 (-24)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 15 of 52 weeks.

22 Apr – 21 Oct
16%33%51%Apr 26Jun 26Jul 26Sep 26Oct 26

Diagnostics & Labs: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months2
Sale orders, 12 months0
Buyers · sellers2 · 0
WhoDidSharesTraded
Mvm Partners, LlcDirectorbought2,202,643at $0.45413 Aug 2026filed 17 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders22-24 on the quarter
New · exited4 · 28
Reported value$6.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Bleichroeder LPunchanged · filed 13 Aug 20267,378,333$3.0M00.0%
MVM Partners, LLCunchanged · filed 14 Aug 20264,700,457$1.9M00.0%
PERKINS CAPITAL MANAGEMENT INCreduced · filed 24 Jul 20261,411,891$580K-64,550−4.4%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026509,674$209K+450,040+754.7%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026503,219$207K+503,219
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026325,084$133K+20,384+6.7%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 2026228,510$94K-316,218−58.1%
Squarepoint Ops LLCnew · filed 14 Aug 2026200,281$82K+200,281
XTX Topco Ltdadded · filed 14 Aug 2026195,039$80K+157,324+417.1%
BlackRock, Inc.added · filed 7 Aug 2026147,063$60K+42,742+41.0%
31 Mar 2023 – 30 Jun 2026
103152Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Eric Bednarski Company insiderDirector · last 13 Aug 20261 · 0
MVM Partners, LLC Company insiderDirector · last 13 Aug 20262 · 0
Brendan OConnell Company insiderVP, Finance and Accounting · last 1 Jun 20260 · 0
Don M. Hardison Company insiderDirector · last 1 Jun 20260 · 0
Hilde Windels Company insiderDirector · last 1 Jun 20260 · 0
John Bellano Company insiderChief Commercial Officer · last 1 Jun 20260 · 0
Joseph Sollee Company insiderOfficer · last 1 Jun 20260 · 0
Koen Hoffman Company insiderDirector · last 1 Jun 20260 · 0
Michael Holder Company insiderDirector · last 1 Jun 20260 · 0
Michael McGarrity Company insiderChief Executive Officer · last 1 Jun 20260 · 0
Sanford Jay Siegel Company insiderDirector · last 1 Jun 20260 · 0

Same industry

CDNA CareDxLeading+97%
NTRA NateraLeading+51%
XGN ExagenLeading+49%
FTRE Fortrea HoldingsLeading+49%
PSNL PersonalisLeading+35%
ADPT Adaptive BiotechnologiesLeading+25%
GH Guardant HealthLeading+22%
BDSX BiodesixLeading+19%

Distance from each stock’s own 150-day average.

From its SEC filings

Share count trendFY 2024 · to 31 Dec 202481.4%

Analyst forecasts

No analyst forecasts yet.